Trial intelligence / Profile preview

Drug interactions between atovaquone for malaria prophylaxis and antiretroviral agents in HIV-1 infected patients (ATOMA)

2006-002864-24Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of atovaquone and proguanil in malaria and human immunodeficiency virus infection (HIV) (4 arms), sponsored by Radboud University Medical Center. Started Jun 2006; status: completed.

02

Drugs

atovaquoneproguanil
03

Conditions

malariahuman immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2006-002864-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002864-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call